![Items used to test blood glucose levels on a picnic table](https://www.uc.edu/news/articles/2024/05/n21251951/jcr:content/image.img.cq5dam.thumbnail.500.500.jpg/1716219012181.jpg)
Diabetes, heart problems and kidney disease are closely linked
UC expert discusses prevention in New York Times article
Heart disease, diabetes and kidney disease, among the most common chronic illnesses in the United States, are all closely connected.
People with diabetes are twice as likely to have heart disease or a stroke and are at risk of developing kidney disease, while heart disease is more likely for those with kidney problems as the heart works harder to pump blood to the kidneys.
The New York Times reports people should pay attention to shared risk factors for these illnesses, including excess body fat, uncontrolled blood sugar, high blood pressure and high cholesterol.
The University of Cincinnati's Estrelita Dixon, MD, commented in the New York Times article on the importance of prevention.
Preventive measures can include adding more fiber, fruit and vegetables to your diet to regulate blood sugar and lower blood pressure and increasing muscle mass through strength training to help with insulin resistance. Just moving in general can be beneficial, and experts recommend aiming for 150 minutes of exercise each week, but Dixon noted gradual steps can still make a difference.
“Don’t think in terms of all or nothing,” said Dixon, division chief and associate professor in the Department of Internal Medicine in UC's College of Medicine.
Read the New York Times story. (Note: Subscription may be required to access full article.)
Featured image at top of diabetes testing supplies. Photo/David Moruzzi/Unsplash.
Related Stories
Dermatology Times features UC research of nail squamous cell carcinoma treatment
June 9, 2022
Dermatology Times featured recent research by University of Cincinnati researchers that showed a low recurrence rate of nail squamous cell carcinoma when treated with surgical approaches other than amputation.
Local 12, Business Courier highlight Blood Cancer Healing Center
February 19, 2024
Local 12 and the Cincinnati Business Courier highlighted the University of Cincinnati Cancer Center's Blood Cancer Healing Center, a comprehensive all-in-one facility dedicated solely to advancing research, treatment and wellness for blood cancer patients, opening this summer.
Medical News Today: Gene mutation may be a key to lung cancer treatment
September 21, 2022
Medical News Today highlighted recent research led by the University of Cincinnati's Pier Paolo Scaglioni, MD, that found targeting components of lipid metabolism and synthesis could lead to an effective lung cancer treatment.
Cure: FDA approves tablet form of blood cancer treatment
August 5, 2022
The University of Cincinnati's John Byrd, MD, was featured in a Cure article on the FDA's approval of the tablet form of the drug Calquence to treat multiple blood cancers.
MedPage Today: Combination treatment promising for certain leukemia patients
May 22, 2023
The University of Cincinnati Cancer Center's Emily Curran recently provided commentary, highlighted by MedPage Today, on a study that showed a combination of antibody-drug conjugate and chemotherapy treatments were promising for older patients with B-cell acute lymphocytic leukemia.
Pennsylvania news: Personalized treatment for deadly blood and bone marrow cancer
April 26, 2023
WFMZ-TV in Allentown, Pennsylvania highlighted the University of Cincinnati's John Byrd and the Beat AML study testing personalized treatment for patients with acute myelogenous leukemia.
Medicine Mentors Podcast: UC's Scaglioni discusses importance of mentorship
October 9, 2023
The University of Cincinnati Cancer Center's Pier Paolo Scaglioni joined the Medicine Mentors Podcast to discuss the qualities to look for in mentors and mentees working in academic medicine.
EveryDay Health: Ways to manage symptoms linked to multiple myeloma
March 26, 2024
The University of Cincinnati's Ed Faber spoke with EveryDay Health about ways to manage symptoms of multiple myeloma including numbness, pain or tingling in your arms and legs.
Regional media highlights UC pancreatic cancer vaccine trial
February 29, 2024
Regional media highlighted the University of Cincinnati Cancer Center being the first site in the Midwest enrolling patients in a new Phase 2 clinical trial testing a vaccine to treat pancreatic cancer.
Yahoo News: Doctors see rising rates of colon cancer in younger people
May 1, 2024
Yahoo News featured comments from the University of Cincinnati's Rekha Chaudhary in a story about rising rates of diagnoses and deaths from colorectal cancers among young people.